A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

An active 62-year-old Rockford man’s life took a turn when he received the news he needed heart surgery. But, what he didn’t ...

The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over radiotherapy alone.1 Mechanisms proposed to explain this effect include ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...